Use of Fetoscopy in Missed Abortion
1 other identifier
interventional
100
1 country
1
Brief Summary
The purpose of this study is to evaluate the use of hysteroscopic embryoscopy or fetoscopy as a powerful diagnostic tool to provide better counseling for couples having experienced pregnancy loss.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2018
CompletedStudy Start
First participant enrolled
January 1, 2019
CompletedFirst Posted
Study publicly available on registry
January 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2021
CompletedJanuary 10, 2019
January 1, 2019
2 years
November 5, 2018
January 7, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Macroscopic anatomic malformations in missed abortions
The number and type of macroscopic anatomic malformations in missed abortions will be determined through visual observation using a fetoscope
Two years
Secondary Outcomes (2)
Minimize intrauterine adhesions through observation
Two years
Prevention of retained conception products
Two years
Study Arms (1)
Fetoscopy in missed abortion
OTHERWomen who have decided to undergo fetoscopy in missed abortion
Interventions
Fetoscopy is a procedure that enables viewing of the fetus through use of a hysteroscope
Eligibility Criteria
You may qualify if:
- Women diagnosed with missed abortion during the first trimester of pregnancy
You may not qualify if:
- Women diagnosed with missed abortion after the first trimester of pregnancy
- Any contraindication for hysteroscopy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hille Yaffe Medical Center
Hadera, 38100, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sergio Haimovich, MD, PhD
Hillel Yaffe Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2018
First Posted
January 10, 2019
Study Start
January 1, 2019
Primary Completion
January 1, 2021
Study Completion
January 1, 2021
Last Updated
January 10, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share